Clinical Trial Update: Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating imatinib mesylate in newly diagnosed acute myeloid leukemia patients who have received chemotherapy has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Imatinib mesylate (Imatinib)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2020-03-04